Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hainan Huanglong Pharmaceutical is a comprehensive pharmaceutical enterprise located in the Haikou National High-tech Industrial Development Zone in Hainan, China. Established in 1992, the company focuses on the production of chemical drugs and Traditional Chinese Medicine (TCM) across multiple therapeutic categories. Its manufacturing capabilities include GMP-certified lines for capsules, tablets, and granules, producing widely used treatments for respiratory infections, digestive issues, and cardiovascular conditions. The company is recognized as a high-tech enterprise in Hainan Province and maintains a significant presence in the regional healthcare market. It primarily serves the domestic Chinese market through a robust distribution network.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hainan Huanglong Pharmaceutical.